MSI STEM RandD Consortium Revenue and Competitors
Estimated Revenue & Valuation
- MSI STEM RandD Consortium's estimated annual revenue is currently $918k per year.
- MSI STEM RandD Consortium's estimated revenue per employee is $114,750
Employee Data
- MSI STEM RandD Consortium has 8 Employees.
- MSI STEM RandD Consortium grew their employee count by -43% last year.
MSI STEM RandD Consortium's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Assistant Director Research & Workforce Development | Reveal Email/Phone |
2 | Research Development Associate | Reveal Email/Phone |
3 | Membership Coordinator | Reveal Email/Phone |
4 | President & CEO | Reveal Email/Phone |
5 | Sharepoint Developer | Reveal Email/Phone |
MSI STEM RandD Consortium Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $3.2M | 30 | -17% | N/A | N/A |
#2 | $3.9M | 46 | 5% | N/A | N/A |
#3 | $0.3M | 6 | -33% | N/A | N/A |
#4 | $14M | 137 | 10% | N/A | N/A |
#5 | $29.1M | 259 | 9% | N/A | N/A |
#6 | $3.3M | 42 | 11% | N/A | N/A |
#7 | $18M | 169 | 14% | N/A | N/A |
#8 | $18.6M | 153 | -1% | N/A | N/A |
#9 | $1.7M | 26 | 18% | N/A | N/A |
#10 | $3.8M | 40 | -7% | N/A | N/A |
What Is MSI STEM RandD Consortium?
MSRDC serves as a strategic asset, solutions provider, and research development partner to more than 60 minority-serving research institutions, federal partners, and private industry collaborators. Our members use a combination of basic, applied, and advanced research to pioneer groundbreaking solutions that drive innovation forward.
keywords:N/A
N/A
Total Funding
8
Number of Employees
$918k
Revenue (est)
-43%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MSI STEM RandD Consortium News
The safety and effectiveness of KEYTRUDA in pediatric patients with MSI-H ... Complications of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).
In Checkmate 142 in MSI-H/dMMR mCRC patients receiving OPDIVO with YERVOY (n=119), serious adverse reactions occurred in 47% of patients. The...
Among the 90 patients with MSI-H or dMMR endometrial carcinoma enrolled in ... Complications of Allogeneic Hematopoietic Stem Cell...
Other Companies in Washington
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.9M | 8 | N/A | N/A |
#2 | $0.5M | 8 | -38% | $0.69M |
#3 | $0.6M | 8 | N/A | N/A |
#4 | $0.5M | 8 | 0% | N/A |
#5 | $1.1M | 8 | 14% | N/A |